Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where L Hajjar is active.

Publication


Featured researches published by L Hajjar.


Critical Care | 2010

Impact of positive fluid balance on survival in critically ill cancer patients

Juliano J.P. Almeida; H Palomba; L Hajjar; V Torres; F Galas; Fa Duarte; D Nagaoka; Rosana Ely Nakamura; J Fukushima; L Yu

Fluid overload has recently been linked to adverse outcomes in critically ill patients, but its impact on the outcomes of cancer patients admitted to intensive care units (ICUs) has not been previously described.


Clinics | 2014

Clinical recommendations for postoperative care after heart transplantation in children: 21 years of a single-center experience

Estela Azeka; Marcelo Biscegli Jatene; Ana Cristina d'Andretta Tanaka; Filomena Regina Barbosa Gomes Galas; L Hajjar; Nana Miura; José Otávio Costa Auler Júnior

Heart transplantation is an option for children with complex congenital heart disease and cardiomyopathies. A patients quality of life and long-term survival depend on successful management of the surgical complications and adverse side effects of immunosuppression. The purpose of this review was to summarize the practical management of postoperative care in this patient population and to make recommendations for the future.


Critical Care | 2010

Outcomes of 3,400 patients with cancer admitted to intensive care unit: a Brazilian prospective study

L Hajjar; F Galas; Juliano Pinheiro de Almeida; D Nagaoka; Fa Duarte; Rosana Ely Nakamura; C Simoes; R Kalil-Filho; Pm Hoff; Joc Auler

ICU admission of critically ill cancer patients was controversial until recently. In the past years, advances in the management of malignancies and organ failures have improved outcomes of patients, resulting in higher rates of survival in the ICU. The aim of this study is to prospectively evaluate the characteristics, short-term and mid-term outcomes of cancer patients requiring intensive care.


Journal of Cardiothoracic and Vascular Anesthesia | 2018

Steroids and Survival in Critically Ill Adult Patients: A Meta-analysis of 135 Randomized Trials

Enrico Antonio Martino; Martina Baiardo Redaelli; Salvatore Sardo; Rosalba Lembo; Vito F. Giordano; Dario Winterton; Laura Ruggeri; L Hajjar; Alberto Zangrillo; Giovanni Landoni

OBJECTIVEnCorticosteroids have important effects on intermediate outcomes in critically ill patients, but their effect on survival is unknown. The objective of this meta-analysis was to analyze the effect on mortality of corticosteroids in critical and perioperative settings.nnnDESIGNnA meta-analysis of randomized trials.nnnSETTINGnPubMed, Embase, BioMed Central, Google Scholar, and the Cochrane Central Register of Controlled Trials were searched to February 1, 2018, for randomized trials comparing corticosteroids with placebo or standard care.nnnPARTICIPANTSnCritically ill or surgical adult patients.nnnINTERVENTIONSnCorticosteroids compared with placebo or standard care.nnnMEASUREMENTS AND MAIN RESULTSnA total of 44,553 patients from 135 studies were included. Overall, mortality in the corticosteroid group and in the control group were similar (16% v 16%; p = 0.9). Subanalyses identified a beneficial effect of corticosteroids on survival in patients with respiratory system diseases (9% v 13%; p < 0.001) and bacterial meningitis (28% v 32%; p= 0.04), and a detrimental effect on survival in patients with traumatic brain injury (22% v 19%; p < 0.001). No differences in mortality were found in patients with cardiac diseases (7% v 6%; p = 0.7), in patients undergoing cardiac surgery (2.8% v 3.2% p = 0.14), and when treatment duration or patient age were considered.nnnCONCLUSIONSnThis meta-analysis documents the safety of corticosteroids in the overall critically ill population with the notable exception of brain injury patients, a setting where the authors confirmed their detrimental effect on survival. A possible beneficial effect of corticosteroids on survival was found among patients with respiratory diseases and in patients with bacterial meningitis.


Survey of Anesthesiology | 2017

Vasopressin Versus Norepinephrine in Patients With Vasoplegic Shock After Cardiac Surgery: The VANCS Randomized Controlled Trial

L Hajjar; Jean Louis Vincent; F. R. Barbosa Gomes Galas; Andrew Rhodes; Giovanni Landoni; E Osawa; Rodrigo Melo; M Sundin; Solimar Miranda Grande; Fábio Antônio Gaiotto; Pablo Maria Alberto Pomerantzeff; Luis Oliveira Dallan; Rafael Alves Franco; Rosana Ely Nakamura; Lurdes Lisboa; J. P. de Almeida; Aline Muller Gerent; Dayenne Hianae Souza; Maria Alice Gaiane; J Fukushima; C Park; Cristiane Zambolim; G. S. Rocha Ferreira; Tânia Mara Varejão Strabelli; Felipe Lourenço Fernandes; L Camara; S Zeferino; Valter Garcia Santos; Marilde de Albuquerque Piccioni; Fabio Biscegli Jatene

<zdoi;10.1097/ALN.0000000000001434> Anesthesiology, V 126 • No 1 85 January 2017 V asoplegic syndrome, characterized by low arterial pressure with normal or elevated cardiac output and reduced systemic vascular resistance,1 occurs in 5 to 25% of patients undergoing cardiac surgery. patients who develop vasoplegic shock after cardiac surgery are at higher risk of organ failure and have increased mortality and longer hospital length of stay.2,3 administration of norepinephrine is currently considered the standard treatment for vasoplegic shock, but all catecholamines have adverse effects, including arrhythmias and myocardial ischemia.4 Furthermore, in severe vasoplegic states, What We Already Know about This Topic


Critical Care | 2011

Red blood cell transfusion is an independent risk factor for cardiovascular complications in adult patients undergoing cardiac surgery: a propensity score-matched analysis

João Alberto Pinheiro Pereira Almeida; F Galas; Jl Vincent; J Fukushima; Rosana Ely Nakamura; R. Kalil Filho; Fabio Biscegli Jatene; Joc Auler; L Hajjar

Red blood cell (RBC) transfusion is associated with a higher occurrence of clinical complications after cardiac surgery. However, the cause-effect relationship is confounded by other risk factors for worse outcomes as advanced age, valve or combined procedure, high EuroSCORE, redo surgery, longer bypass time and previous anemia. The objective of this study was to evaluate the effect of RBC transfusion in a propensity score-matched case-control analysis.


Critical Care | 2011

Prognostic factors for acute kidney injury development in critically ill cancer patients

L Hajjar; Henrique Palomba; J Almeida; J Fukushima; Rosana Ely Nakamura; F Galas; V Torres; R. Kalil Filho; L Yu

Acute kidney injury (AKI) in cancer patients is a complication that causes substantial morbidity and mortality.


Arquivos Brasileiros De Cardiologia | 2011

I Diretriz Brasileira de Cardio-Oncologia da Sociedade Brasileira de Cardiologia

R. Kalil Filho; L Hajjar; Fernando Bacal; Paulo M. Hoff; M del P Diz; F Galas


Critical Care | 2013

Transfusion Requirements in Surgical Oncology Patients (TRISOP): a randomized, controlled trial

J Almeida; F Galas; E Osawa; J Fukushima; S Moulin; C Park; Elisangela Pinto Marinho de Almeida; S Vieira; Jl Vincent; Andrew Rhodes; M Balzan; J Inacio; Henrique Palomba; Rosana Ely Nakamura; F Bergamin; A Sandrini; Ulysses Ribeiro; J Auler; L Hajjar


Critical Care | 2012

Randomized comparison of fibrinogen concentrate versus cryoprecipitate for bleeding control in pediatric cardiac surgery (FICCS study)

F Galas; L Hajjar; B Sorensen; Juliano Pinheiro de Almeida; M Sundin; V Guimaraes; S Zefferino; L Camara; F Maua; M Moreira; C Puttini; M Carmona; J Auler; R Nakamura

Collaboration


Dive into the L Hajjar's collaboration.

Top Co-Authors

Avatar

F Galas

University of São Paulo

View shared research outputs
Top Co-Authors

Avatar

J Fukushima

University of São Paulo

View shared research outputs
Top Co-Authors

Avatar

E Osawa

University of São Paulo

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

C Park

University of São Paulo

View shared research outputs
Top Co-Authors

Avatar

J Auler

University of São Paulo

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

L Camara

University of São Paulo

View shared research outputs
Top Co-Authors

Avatar

R. Kalil Filho

University of São Paulo

View shared research outputs
Top Co-Authors

Avatar

Jl Vincent

Université libre de Bruxelles

View shared research outputs
Researchain Logo
Decentralizing Knowledge